Not adopted
This amendment was never taken up, and the bill finished without it. It was never voted on.
Its path through Congress
- Introduced
- Pending Consideration
- Failed
What this amendment would do
The amendment submitted by Mr. Cornyn (SA 1260) reauthorizes and updates federal laws related to the Office of National Drug Control Policy and anti-drug programs through fiscal year 2031. It aims to change and add provisions focusing heavily on fentanyl tracking, support for life-saving overdose reversal medications like naloxone, and bolstering law enforcement resources.
Specifically, the amendment aims to add or change the following:
-
Support for Reversal Agents: Adds tertiary prevention support, such as opioid antagonists and overdose reversal agents like naloxone, and drug detection testing to the responsibilities of the Office of National Drug Control Policy.
-
Fentanyl and Precursor Interdiction: Creates specific definitions for precursor chemicals and emerging drug threats, and establishes funding, reporting, and prosecutor reassignments specifically targeted at disrupting fentanyl trafficking organizations.
-
Border and Immigration Coordination: Requires coordination with the Secretary of Homeland Security and the Attorney General regarding immigration enforcement and drug trafficking, and requires strategic plans for border counternarcotics efforts, including the Caribbean region.
-
Reporting Requirements: Mandates reports on life-saving opioid overdose reversal studies, pill press machine regulations, and privacy protections for data analytical services programs like Hemisphere.
-
Grant Reauthorizations: Extends and adjusts funding authorizations for various anti-drug abuse programs, drug-free communities support, and coalition enhancement grants through fiscal year 2031.
- 3/12/2025
- Senate amendment submitted
This bill has no cosponsors